Legalizing the production of opium for medical use is neither viable or necessary

May 02, 2008

Proposals to legalise the production of opium in Afghanistan for medical use are unworkable and unnecessary, says the Minister of State for Africa, Asia, and the United Nations in an editorial in this week’s BMJ.

Writing in response to an article* in the BMJ that called for legal cultivation of poppies to combat the shortage of opiate medicines, Mark Malloch-Brown argues that a sustainable solution to the problem of illegal opium production requires attractive, economically viable legal livelihoods, security and good governance in Afghanistan, as well as a determined effort to reduce demand around the world.

Around 90% of the world’s opium comes from Afghanistan, most of it intended for the illegal market. Opium offers farmers a quick turnover and high returns, but production continues to drive instability and insurgency.

The Afghanistan government lacks the resources, institutional capacity, and control mechanisms to ensure that opium grown would be purchased legally, he says. In addition, those cultivating opium for legal medical usage would be in direct competition with illegal traffickers, which in turn could drive up the price of opium and encourage increased cultivation.

He suggests that the demand for legal opium is better met by established sources of production from countries like Turkey and Australia, where there are fewer problems with security and stability and where production costs are up to six times cheaper.

He also points out that a greater supply of medical opiates is not needed because the global demand for medical and scientific purposes is already fully met.

According to Malloch-Brown, the essential challenge is to create development initiatives and economic incentives that provide attractive legal alternatives for farmers. This can be done by improving the infrastructure and local government capacity, giving farmers improved access to markets, land, water, credit, food security, and employment, he argues.

The question of demand is the key, he says. The arguments regarding opium production are global and cannot be controlled with local strategies.

“Only by reducing demand [for heroin] on the streets everywhere will the producers and traffickers on the streets of Afghanistan be given the best reason to follow their alternative livelihoods”, he concludes.

Source: British Medical Journal

Explore further: FDA OKs Cubist antibiotic for serious infections

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

FDA OKs Cubist antibiotic for serious infections

6 hours ago

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.